ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Early Response Evaluation in NSCLC Patients Treated With Immunotherapy

The Netherlands Cancer Institute · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
nansclc
nsclc, stage iv, pd-l1 expression, eligible for treatment with nivolumab, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 992271
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.